Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID‐19 vaccination

As more people become vaccinated against the SARS‐CoV‐2 virus, reports of delayed cutaneous hypersensitivity reactions are beginning to emerge.

[1]  J. DeKoven,et al.  Pityriasis rosea‐like eruptions following vaccination with BNT162b2 mRNA COVID‐19 Vaccine , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  K. Watsky,et al.  Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series. , 2021, JAMA dermatology.

[3]  B. Morgado,et al.  Pityriasis rosea‐like eruption after Pfizer–BioNTech COVID‐19 vaccination , 2021, The British journal of dermatology.

[4]  M. Fernández-Guarino,et al.  Skin manifestations of the BNT162b2 mRNA COVID‐19 vaccine in healthcare workers. ‘COVID‐arm’: a clinical and histological characterization , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  J. Lipoff,et al.  Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases , 2021, Journal of the American Academy of Dermatology.

[6]  C. Llanos,et al.  Lichen planus arising after COVID‐19 vaccination , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  O. Merimsky,et al.  COVID-19 Vaccine-Induced Radiation Recall Phenomenon , 2021, International Journal of Radiation Oncology*Biology*Physics.

[8]  M. Lebwohl,et al.  “COVID arm”: A reaction to the Moderna vaccine , 2021, JAAD Case Reports.

[9]  L. Klimek,et al.  Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA , 2021, Allergo Journal International.

[10]  D. Klonoff,et al.  COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. , 2021, European review for medical and pharmacological sciences.

[11]  T. Shimabukuro,et al.  Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine. , 2021, JAMA.

[12]  N. Mesinkovska,et al.  The art of prevention: COVID-19 vaccine preparedness for the dermatologist☆☆☆ , 2021, International Journal of Women's Dermatology.

[13]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[14]  Uni Wong,et al.  Blistering autoimmune skin reaction following SHINGRIX vaccination in an ulcerative colitis patient: Case report and literature review. , 2020, Vaccine.

[15]  J. Callen,et al.  Type II mixed cryoglobulinemia following influenza and pneumococcal vaccine administration , 2019, JAAD case reports.

[16]  R. Bergman,et al.  Anti-laminin-332 mucous membrane pemphigoid developing after a diphtheria tetanus vaccination. , 2013, JAMA dermatology.

[17]  D. Wendling,et al.  Vascular purpura and cryoglobulinemia after influenza vaccination. Case-report and literature review. , 1999, Revue du rhumatisme.

[18]  Kennedy,et al.  Does influenza vaccination induce bullous pemphigoid? A report of four cases , 1998, The British journal of dermatology.

[19]  Ping Li,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020 .